Back

Influence of Atrial Fibrillation on Efficacy of Omecamtiv Mecarbil in Heart Failure: The GALACTIC-HF Trial

29 June 2021 (17:00 - 17:20)
Organised by:
Congress Presentation Part of: Late-Breaking Trials 1 Pharmacotherapy HFA Premium Access Heart Failure 2021

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

2 More presentations in this session

Presentation thumbnail
The effect of intravenous ferric-carboxymaltose on cardiac reverse remodeling following cardiac resynchronization therapy - The IRON CRT trial.
Professor P. Martens (Genk, BE)
Slides Video
Presentation thumbnail
Finerenone in patients with chronic kidney disease and type 2 diabetes, with and without a history of heart failure: a secondary analysis of the FIDELIO-DKD trial
Professor G. Filippatos (Athens, GR)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Trials 1
Video

The Event

Event poster

Heart Failure 2021

29 June 2021 17:00 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources